These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3533762)

  • 1. [A simple enzyme assay for the simultaneous determination of penicillin derivatives and clavulanic acid in biological fluids].
    Cullmann W; Dick W
    Immun Infekt; 1986 Sep; 14(5):188-90. PubMed ID: 3533762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of an inducible beta-lactamase from Proteus vulgaris.
    Cullmann W; Seibert G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Aug; 262(2):208-19. PubMed ID: 3538717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clavulanate-potentiated ticarcillin: high-performance liquid chromatographic assays for clavulanic acid and ticarcillin isomers in serum and urine.
    Watson ID
    J Chromatogr; 1985 Feb; 337(2):301-9. PubMed ID: 3988860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple assay of beta-lactamase with agar medium containing a chromogenic cephalosporin, pyridinium-2-azo-p-dimethylaniline chromophore (PADAC).
    Kobayashi S; Arai S; Hayashi S; Sakaguchi T
    Antimicrob Agents Chemother; 1988 Jul; 32(7):1040-5. PubMed ID: 3263833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Direct determination of clavulanic acid in biological fluids using HPLC].
    Jehl F; Monteil H; Brogard JM
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):702-6. PubMed ID: 3309800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriological investigations with beta-lactamase inhibitors.
    Ullmann U
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):222-9. PubMed ID: 6289565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-pyrrylderivatives of penicillins. Kinetics and inhibition studies with clavulanic acid of a Bacillus cereus beta-lactamase.
    Díez MT; Arín MJ; Negro A; Salto F
    Pharmazie; 1987 Jun; 42(6):415-6. PubMed ID: 3118398
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of beta-lactamase inhibitors.
    Sutherland R
    J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains.
    de Sá Del Fiol F; Rocha De Mattos Filho T; Groppo FC
    Braz J Infect Dis; 2000 Feb; 4(1):36-42. PubMed ID: 10788844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical antibacterial activities of beta-lactams against Proteus vulgaris: mechanism of the paradoxical effect.
    Ikeda Y; Nishino T
    Antimicrob Agents Chemother; 1988 Jul; 32(7):1073-7. PubMed ID: 3056246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
    Paniagua GL; Monroy E; García O; Vaca S
    Rev Latinoam Microbiol; 1998; 40(3-4):128-34. PubMed ID: 10932741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sensitive assay for clavulanic acid and sulbactam in biological fluids by high-performance liquid chromatography and precolumn derivatization.
    Shah AJ; Adlard MW; Stride JD
    J Pharm Biomed Anal; 1990; 8(5):437-43. PubMed ID: 2081205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of beta-lactamase inhibitors.
    Rolinson GN
    Surg Gynecol Obstet; 1991; 172 Suppl():11-6. PubMed ID: 2024221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Beta-lactamase inhibitors and their possible therapeutic significance].
    Fomina IP; Lobuseva AN; Navashin SM
    Antibiotiki; 1984 Feb; 29(2):142-8. PubMed ID: 6367631
    [No Abstract]   [Full Text] [Related]  

  • 15. A study of antibacterial activity of furbenicillin against beta-lactamase producing gram-negative organisms.
    Yang YJ; Li JT
    Chin Med J (Engl); 1984 May; 97(5):345-51. PubMed ID: 6439485
    [No Abstract]   [Full Text] [Related]  

  • 16. [Stability of beta-lactamase inhibitors and beta-lactam antibiotics in parenteral formulations as well as in body fluids and tissue homogenates. Comparison of sulbactam, clavulanic acid, ampicillin and amoxicillin].
    Wildfeuer A; Räder K
    Arzneimittelforschung; 1991 Jan; 41(1):70-3. PubMed ID: 2049115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases.
    Grace ME; Fu KP; Gregory FJ; Hung PP
    Drugs Exp Clin Res; 1987; 13(3):145-8. PubMed ID: 3040368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrophotometric determination of the stability of clavulanic acid and its ether and amine derivatives in serum and urine.
    Kenig MD
    Analyst; 1988 May; 113(5):761-4. PubMed ID: 3414965
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative study of the activity of first and second generation cephalosporins and their combinations with beta-lactamase inhibitors against Bacteroides fragilis.
    Martin MA; Liebana J; Castillo AM; Gutierrez J; Piédrola G
    Microbios; 1991; 67(272-273):195-202. PubMed ID: 1779879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification of a cephalosporinase susceptible to clavulanic acid in a clinical strain of Serratia fonticola].
    Farzaneh S; Péduzzi J; Demachy MC; Barthélémy M; Labia R
    Pathol Biol (Paris); 1995 Apr; 43(4):315-9. PubMed ID: 7567122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.